News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 2
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about biosimilar development trends.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about biosimilar development trends.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Deploys Agentic AI Capabilities for Agency Staff
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
5
